- Home
- TRVI vs BV Comparison
TRVI vs BV Comparison
Compare TRVI & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- BV
- Stock Information
- Founded
- TRVI 2011
- BV 1939
- Country
- TRVI United States
- BV United States
- Employees
- TRVI N/A
- BV N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- BV Business Services
- Sector
- TRVI Health Care
- BV Consumer Discretionary
- Exchange
- TRVI Nasdaq
- BV Nasdaq
- Market Cap
- TRVI 1.4B
- BV 1.4B
- IPO Year
- TRVI 2019
- BV 2018
- Fundamental
- Price
- TRVI $10.91
- BV $12.13
- Analyst Decision
- TRVI Strong Buy
- BV Buy
- Analyst Count
- TRVI 9
- BV 6
- Target Price
- TRVI $20.72
- BV $17.98
- AVG Volume (30 Days)
- TRVI 1.6M
- BV 701.2K
- Earning Date
- TRVI 11-10-2025
- BV 11-19-2025
- Dividend Yield
- TRVI N/A
- BV N/A
- EPS Growth
- TRVI N/A
- BV N/A
- EPS
- TRVI N/A
- BV 0.12
- Revenue
- TRVI N/A
- BV $2,698,700,000.00
- Revenue This Year
- TRVI N/A
- BV $0.10
- Revenue Next Year
- TRVI N/A
- BV $2.09
- P/E Ratio
- TRVI N/A
- BV $101.38
- Revenue Growth
- TRVI N/A
- BV N/A
- 52 Week Low
- TRVI $2.36
- BV $11.81
- 52 Week High
- TRVI $11.83
- BV $18.89
- Technical
- Relative Strength Index (RSI)
- TRVI 55.76
- BV 31.88
- Support Level
- TRVI $10.22
- BV $12.10
- Resistance Level
- TRVI $11.82
- BV $12.27
- Average True Range (ATR)
- TRVI 0.55
- BV 0.28
- MACD
- TRVI -0.08
- BV -0.05
- Stochastic Oscillator
- TRVI 30.12
- BV 4.89
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About BV BrightView Holdings Inc.
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.